Organigram Announces 34% Decrease in Q4 Revenues In Preliminary Results

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced preliminary fourth quarter revenues this evening, providing guidance for revenues of $16.3 million for the fourth quarter. On a quarter over quarter basis revenues have declined by 34.14%, from $24.8 million in the third quarter. The firm reported that it expects to report negative adjusted EBITDA as a result.

The total revenue figure provided by Organigram represents $20.0 million in net sales, plus returns and pricing adjustments to the tune of $3.7 million. The firm placed blame on the rollout of provincial distribution for adult use cannabis as the underlying reason for poor sales, while highlighting Ontario’s retail network in particular. The firm also placed blame on “increased industry supply” for its lack of sales growth.

The bright side, however is that the firm indicated it has seen sequential improvement in its cost per gram of cultivation and yield, however no hard figures were provided.

Organigram expects to report a cash position of $47.9 million including short term investments, while having $49.6 million in current and long term debt. Subsequent to the end of the quarter, the firm has also drawn $15.0 million from a $115 million term loan. That loan has $50 million remaining of available credit.

In terms of the current quarter, Organigram provided minimal color, indicating that they have shipped more than they had by this point in the previous quarter.

Organigram is to report full fourth quarter financials on November 25 before market open. The firm closed today’s session at $4.46 on the TSX.


Information for this briefing was found via Sedar and Organigram Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Organigram Signs Distribution Agreement With Shoppers

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) is working on strengthening its distribution lines. The company...

Thursday, January 16, 2020, 09:18:20 AM

Organigram: Haywood Raises Estimates Betting On Increased Market Share

On January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter earnings for 2022....

Saturday, January 15, 2022, 11:09:00 AM

Organigram Reports Revenue Growth in Fiscal 2024, But Net Losses Continue

Organigram Holdings Inc. (TSX: OGI) has reported its financial results for fiscal year 2024, ending...

Wednesday, December 18, 2024, 10:18:00 AM

Organigram: Canaccord Lowers Price Target To $2.50

Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced...

Tuesday, December 1, 2020, 11:17:00 AM

Raymond James Reiterates $6 Price Target On Organigram Holdings

On April 6th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they acquired cannabis 2.0...

Thursday, April 8, 2021, 10:37:00 AM